Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DYADIC INTERNATIONAL INCDYAI · Entity 7611 | Director | January 02, 2026 | January 06, 2026 |
| uniQure N.V.QURE · Entity 4162 | Director | June 30, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DYADIC INTERNATIONAL INC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 81,201 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Exercise / conversion · Acquired 21,552 · Balance 81,201 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Exercise / conversion · Disposed 21,552 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5: The restricted stock units previously issued and vested upon the first anniversary of the date of grant, subject to continued service as a member of the board of directors, were settled 100% in Issuer's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 39,894 |
Reported balance
After 2026-01-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-02 · Grant · Acquired 39,894 · Balance 39,894 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3: Annual grant of restricted stock units. F4: The restricted stock units will be settled 100% in Issuer's common stock when vested upon the first anniversary of the date of grant, subject to continued service as a member of the board of directors. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.94 · Expires 2036-01-02 | Direct | 67,500 |
Reported balance
After 2026-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-02 · Grant · Acquired 67,500 · Balance 67,500 F2: Annual grant of stock options. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: Annual grant of stock options.
F3: Annual grant of restricted stock units.
F4: The restricted stock units will be settled 100% in Issuer's common stock when vested upon the first anniversary of the date of grant, subject to continued service as a member of the board of directors.
F5: The restricted stock units previously issued and vested upon the first anniversary of the date of grant, subject to continued service as a member of the board of directors, were settled 100% in Issuer's common stock.
uniQure N.V.
Report date June 30, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 25,996 |
Ending reported balance
After 2026-06-30 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-30 · Exercise / conversion · Acquired 4,107 · Balance 30,103 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 2 · 2026-06-30 · Sale · Disposed 4,107 · Balance 25,996 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Row 3 · 2026-06-30 · Exercise / conversion · Acquired 17,060 · Balance 43,056 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 4 · 2026-06-30 · Sale · Disposed 17,060 · Balance 25,996 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.00 · Expires 2031-02-25 | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-30 · Exercise / conversion · Disposed 4,107 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4: The Stock Option vested in full on February 25, 2022. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.18 · Expires 2033-06-13 | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-30 · Exercise / conversion · Disposed 17,060 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5: The Stock Option vested in full on June 13, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote
F4: The Stock Option vested in full on February 25, 2022.
F5: The Stock Option vested in full on June 13, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2023 Filed Feb 6, 2024 22:28 UTC | uniQure N.V. QURE · Entity 4162 | GiftOrdinary Shares | 12,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-24-000112 · ownership.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,719 F1 · kind: On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. F1 · price: On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. Read SEC document |
| June 23, 2023 Filed Feb 6, 2024 22:28 UTC | uniQure N.V. QURE · Entity 4162 | GiftOrdinary Shares | 12,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-24-000112 · ownership.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,419 F1 · kind: On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. F1 · price: On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 21:23 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,280 | $18.93 | $43,160.40 |
DisclosureSEC source: 0000904454-23-000396 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,119 F3 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F3 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.89 to $18.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2023 Filed Jun 20, 2023 21:23 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 17,060 | $0.00 Strike: $20.18 | $0.00 |
DisclosureSEC source: 0000904454-23-000396 · edgar.xml · derivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,060 Underlying: Ordinary Shares · 17,060 shares Expires 2033-06-13 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 13, 2023 Filed Jun 20, 2023 21:23 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-23-000396 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,399 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:10 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 384 | $19.99 | $7,676.16 |
DisclosureSEC source: 0000899243-23-006573 · doc4.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,699 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.99 to $20.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:28 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantRestricted Stock Unit · Derivative | 27,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000578 · rdgdoc.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,174 Underlying: Common Stock · 27,174 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · kind: Receipt of restricted stock units as a result of reduction in director cash compensation. F4 · derivative.exercise_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as board of director. F4 · derivative.expiration_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as board of director. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:28 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 52,500 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001437749-23-000578 · rdgdoc.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2033-01-02 F1 · shares: Annual grant of stock options. Read SEC document |
| November 21, 2022 Filed Jan 6, 2023 00:31 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GiftCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000585 · rdgdoc.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,407 F1 · shares: On November 21, 2022, the reporting person, in connection with his estate plan, made a gift of 33,150 shares to each of his adult children. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. F2 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of shares. Read SEC document |
| November 21, 2022 Filed Jan 6, 2023 00:31 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GiftCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000585 · rdgdoc.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,557 F1 · shares: On November 21, 2022, the reporting person, in connection with his estate plan, made a gift of 33,150 shares to each of his adult children. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. F2 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of shares. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:53 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 17,810 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0000904454-22-000360 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,810 Underlying: Ordinary Shares · 17,810 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:53 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 9,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-22-000360 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,083 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 20:11 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001437749-22-014961 · rdgdoc.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-09 F1 · shares: Grant of stock options as a result of a reduction in director cash compensation. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:42 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 600 | $16.76 | $10,056.00 |
DisclosureSEC source: 0000904454-22-000219 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,003 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.76 to $16.82. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:38 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $16.04 | $0.00 |
DisclosureSEC source: 0000904454-22-000197 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,645 Underlying: Ordinary Shares · 2,645 shares Expires 2032-02-24 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:38 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 1,534 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-22-000197 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,603 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:32 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 52,500 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001437749-22-000456 · rdgdoc.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2032-01-02 F1 · shares: Annual grant of stock options. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:28 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 504 | $37.60 | $18,950.40 |
DisclosureSEC source: 0000904454-21-000299 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,069 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.76 to $37.60. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0000904454-21-000243 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,107 Underlying: Ordinary Shares · 4,107 shares Expires 2031-02-25 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-21-000243 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,573 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:24 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 52,500 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001437749-21-000294 · rdgdoc.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2031-01-03 F1 · shares: Annual grant of stock options. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:41 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 3,620 | $0.00 Strike: $51.81 | $0.00 |
DisclosureSEC source: 0000904454-20-000253 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620 Underlying: Ordinary Shares · 3,620 shares Expires 2030-02-27 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 20:41 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000253 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,191 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 28, 2020 Filed Jan 31, 2020 02:32 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 806 | $62.20 | $50,133.20 |
DisclosureSEC source: 0000904454-20-000120 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,128 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:50 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001213809-20-000005 · wf-form4_157810260873976.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-01-01 F1 · shares: Annual grant of stock options. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 22:08 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $5.83 | $0.00 |
DisclosureSEC source: 0001213809-19-000048 · wf-form4_156167326633528.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-24 Read SEC document |
| January 28, 2019 Filed Jan 31, 2019 22:19 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,210 | $31.31 | $37,885.10 |
DisclosureSEC source: 0000904454-19-000142 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,934 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.26 to $31.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 25, 2019 Filed Jan 31, 2019 22:13 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-19-000140 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 25, 2019 Filed Jan 31, 2019 22:13 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000140 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,144 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 15:34 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,878 | $18.53 | $53,329.34 |
DisclosureSEC source: 0000904454-18-000089 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,914 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.41 to $18.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 15:32 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-18-000058 · edgar.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,390 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 F3 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 15:32 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 4,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-18-000058 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,792 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. F2 · balance_after: Includes 11,000 restricted share units that vested in full on January 27, 2018 previously disclosed by the Reporting Person in Table II. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:57 UTC | uniQure N.V. QURE · Entity 4162 | GrantRestricted Stock Units · Derivative | 11,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-003697 · doc1.xml · derivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Ordinary Shares · 11,000 shares Expires not disclosed F2 · derivative.exercise_date: The Restricted Stock Unit vests 100% on January 27, 2018. F3 · derivative.expiration_date: Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:57 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001140361-17-003697 · doc1.xml · derivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Ordinary Shares · 11,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The Stock Option vests 100% on January 27, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.